Pages that link to "Q34750568"
Jump to navigation
Jump to search
The following pages link to A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines (Q34750568):
Displaying 50 items.
- Gene expression-based risk score in diffuse large B-cell lymphoma (Q42153541) (← links)
- Development of gene expression-based risk score in cytogenetically normal acute myeloid leukemia patients (Q42409849) (← links)
- Heat shock factor 1 is a potent therapeutic target for enhancing the efficacy of treatments for multiple myeloma with adverse prognosis. (Q42548885) (← links)
- The Bcl-2 specific BH3 mimetic ABT-199: a promising targeted therapy for t(11;14) multiple myeloma (Q42748426) (← links)
- Gene Expression Profiles in Myeloma: Ready for the Real World? (Q43847809) (← links)
- New prognostic markers, determined using gene expression analyses, reveal two distinct subtypes of chronic myelomonocytic leukaemia patients (Q43880033) (← links)
- Expression of osteoblast and osteoclast regulatory genes in the bone marrow microenvironment in multiple myeloma: only up-regulation of Wnt inhibitors SFRP3 and DKK1 is associated with lytic bone disease. (Q43965394) (← links)
- Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins (Q44618950) (← links)
- Low-risk identification in multiple myeloma using a new 14-gene model (Q45182114) (← links)
- Insights on Genomic and Molecular Alterations in Multiple Myeloma and Their Incorporation towards Risk-Adapted Treatment Strategy: Concise Clinical Review. (Q47095937) (← links)
- CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma (Q47125786) (← links)
- Decitabine and Melphalan Fail to Reactivate p73 in p53 Deficient Myeloma Cells (Q47218594) (← links)
- IL-6 supports the generation of human long-lived plasma cells in combination with either APRIL or stromal cell-soluble factors. (Q50861647) (← links)
- A simple flow cytometry-based barcode for routine authentication of multiple myeloma and mantle cell lymphoma cell lines. (Q50958153) (← links)
- DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells. (Q52676395) (← links)
- AMO1 (Q54749810) (← links)
- ANBL-6 (Q54749908) (← links)
- BCN (Q54795699) (← links)
- JIM3 (Q54898926) (← links)
- JJN-3 (Q54898954) (← links)
- Karpas-620 (Q54899502) (← links)
- KMM-1 (Q54900126) (← links)
- KMS-11 (Q54900162) (← links)
- KMS-12-BM (Q54900168) (← links)
- KMS-12-PE (Q54900169) (← links)
- L-363 (Q54900864) (← links)
- LP-1 (Q54902910) (← links)
- MDN (Q54904815) (← links)
- MM1.S (Q54906038) (← links)
- NAN-1 (Q54907474) (← links)
- NAN-3 (Q54907476) (← links)
- NAN-6 (Q54907479) (← links)
- NCI-H929 (Q54908142) (← links)
- OPM-2 (Q54936482) (← links)
- RPMI-8226 (Q54951245) (← links)
- SBN (Q54952216) (← links)
- SK-MM-2 (Q54954410) (← links)
- U266B1 (Q54973634) (← links)
- XG-1 (Q54994677) (← links)
- XG-10 (Q54994695) (← links)
- XG-11 (Q54994696) (← links)
- XG-12 (Q54994697) (← links)
- XG-13 (Q54994699) (← links)
- XG-14 (Q54994700) (← links)
- XG-16 (Q54994701) (← links)
- XG-19 (Q54994703) (← links)
- XG-2 (Q54994704) (← links)
- XG-20 (Q54994705) (← links)
- XG-21 (Q54994706) (← links)
- XG-24 (Q54994708) (← links)